NSC |
Compound |
Enrichment |
Correlation |
NSC 707148 |
Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) |
0.0187206825450448 |
0.31104842 |
NSC 72942 |
DL-Noformicin |
0.0187206825450448 |
0.065431295 |
NSC 73300 |
Null |
0.0187206825450448 |
0.56433125 |
NSC 80141 |
Null |
0.0187206825450448 |
-0.038568327 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0208632511155816 |
-0.057729127 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.0208632511155817 |
-0.048975714 |
NSC 615441 |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.0208632511155817 |
0.47841893 |
NSC 638636 |
Null |
0.0208632511155817 |
0.2481834 |
NSC 675004 |
Null |
0.0208632511155817 |
0.0064491494 |
NSC 693639 |
Ethanone, 1-(2-pyrimidinyl)-, (2-benzoxazolyl)hydrazone |
0.0208632511155817 |
0.53443047 |